Global PTA
Balloon Catheter Market, by Material Type (Polyurethane, Nylon, and
Others), by Application (Coronary Artery Disease and Peripheral Vascular
Disease), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, and
Others), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa), was valued at US$ 1,127.7 million in 2017, and is
projected to exhibit a CAGR of 6.8% over the forecast period (2019 – 2026), as
highlighted in a new report published by.
Increasing prevalence of
urological and cardiovascular diseases is expected to augment the PTA balloon
catheter market growth Increasing number of cardiovascular diseases and
urological diseases fuels the global PTA balloon catheter market growth.
Increase in number of regulatory approvals, product launches and mergers and
acquisitions are expected to augment the growth in the global PTA balloon
catheter market. For instance, in November 2015, SurModics, Inc. (Nasdaq: SRDX), a leading
provider of medical device and in vitrodiagnostic technologies, today announced
it has acquired Creagh Medical Ltd., an innovative developer and manufacturer
of percutaneous transluminal angioplasty (PTA) balloon catheters. The
acquisition is a major step forward in SurModics’ strategy to transform its
Medical Device business from being a provider of coating technologies, to
offering whole-product solutions to medical device customers in the large and
growing global interventional vascular market.
Increasing number of product launches and approvals is also expected to
fuel the global PTA balloon catheter market growth. For instance, in December
2016, BrosMed announced the U.S FDA 510(k) clearance and launch of its Hermes
NC 0.035 OTW PTA, Achilles NC 0.018 OTW PTA, and Castor NC 0.014 OTW PTA
balloon dilatation catheter for the treatment of patients with peripheral
arterial diseases.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2815
Furthermore, in April 2019,
Becton, Dickinson and Company announced the launch of UltraScore 014 focused
force percutaneous transluminal angioplasty (PTA) balloon. The UltraScore
balloon is intended to dilate stenoses in the iliac, femoral, ilio-femoral,
popliteal, infra-popliteal and renal arteries and for the treatment of
obstructive lesions of native or synthetic arteriovenous dialysis
fistulae. The FDA has identified some
class 1 recalls which are most serious types of recalls. By using these devices
may cause the serious injuries or death. For instance, on May 2019, Cook
Medical recalled the Advance Enforcer 35 Focal Force PTA balloon catheter due
to the balloon bursting below the rated burst pressure.
Browse 32 Market Data Tables and
20 Figures spread through 178 Pages and in-depth TOC on “PTA Balloon Catheter
Market”- Global Forecast to 2026, by Material Type (Polyurethane, Nylon, and
Others), by Application (Coronary Artery Disease and Peripheral Vascular
Disease), by End User (Hospitals or Clinics, Ambulatory Surgical Centers, and
Others), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa)
High potency PTA balloon catheter
are considered as a growth opportunity for manufacturers and Increasing demand
for angioplasty surgery is expected to propel the PTA balloon catheter market
growth. Moreover, in December 2017, iVascular announced the release of new
Oceanus 14 Pro PTA balloon catheter, which received CE mark approval to dilate
stenoses in femoral, popliteal, and infrapopliteal arteries, and for the treatment
of obstructive lesions in arteriovenous dialysis fistulae.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/pta-balloon-catheter-market-2815
Key Takeaways of the PTA balloon
catheter Market:
The global PTA balloon catheter
market is expected to exhibit a CAGR of 6.8% over the forecast period, owing to
increasing demand for high potency PTA balloon catheters, rising demand for
offering PTA balloon catheter manufacturing, and increasing prevalence of
cardiovascular disease.
Among application, peripheral
vascular disease segment held dominant position in the PTA balloon catheter
market in 2018, owing to broad range of peripheral vascular applications. For
instance, in May 2018, Surmodics Inc., a provider of medical device and
in-vitrodiagnostic technologies, received the U.S. Food and Drug Administration
(FDA) 510(k) clearance for its .018-inch Low-Profile percutaneous transluminal
angioplasty (PTA) balloon dilation catheter, designed and indicated for a broad
range of peripheral vascular applications.
Major players operating in the
global PTA balloon catheter market include, Medtronic, Terumo, Cardinal Health,
Boston Scientific, AndraTec, Cook Medical, Biotronik, Abbott, Creagh Medical,
TriReme Medical, and Natec Medical.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2815
About Coherent
Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment